News
-
-
-
-
PRESS RELEASE
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
MIRA Pharmaceuticals, Inc. announces promising results for novel oral ketamine analog Ketamir-2 in providing superior pain relief compared to current treatments. Preparing for Phase 1 clinical trials and exploring potential in PTSD -
-
-
-
PRESS RELEASE
Forum Asset Management Announces ALMA @ Cabbagetown: An Innovative and Attainable Approach Addressing Toronto's Student Housing Crisis
Forum Asset Management announces ALMA @ Cabbagetown Toronto, a development addressing student housing shortage and offering high-quality, attainable options -
PRESS RELEASE
Tier One Silver Reports Channel Sampling Results; Extends the Cambaya Target Area of Highly Prospective Silver Targets
Tier One Silver Inc. reports new channel sampling results from its silver-gold corridors Cambaya I and II. High-grade precious metals target areas identified through extensive surface sampling -
PRESS RELEASE
Corporation Métaux Précieux du Québec débute un premier programme de forage sur la découverte de lithium à haute teneur de Ninaaskumuwin, détenue à 100 %, située près du projet Galaxy qui sera acquis par Rio Tinto, Baie-James, Québec, annonce u
La Corporation Métaux Précieux du Québec débute un programme de forage au diamant sur son prospect de lithium de Ninaaskumuwin. Un placement privé est également annoncé